S100B and obesity disorder: In conclusion, taken together, the above data suggest a role for adipose S100B in obesity/diabetes processes and for non-neurological metabolic diseases in general terms (Figure 2), re-proposing the putative role played by astrocytic S100B in neuroinflammatory/neurodegenerative processes.